Are we underestimating seroprevalence of SARS-CoV-2?
作者信息
Burgess Stephen, Ponsford Mark J, Gill Dipender
机构信息
MRC Biostatistics Unit, School of Clinical Medicine, University of Cambridge, Cambridge, UK
Immunodeficiency Centre of Wales, University Hospital Wales, Cardiff, UK.
出版信息
BMJ. 2020 Sep 3;370:m3364. doi: 10.1136/bmj.m3364.
Abstract
摘要
相似文献
1
Are we underestimating seroprevalence of SARS-CoV-2?我们是否低估了新冠病毒的血清阳性率？
BMJ. 2020 Sep 3;370:m3364. doi: 10.1136/bmj.m3364.
2
Seroprevalence of SARS-Cov-2 in 646 professionals at the Rothschild Foundation Hospital (ProSeCoV study).罗斯柴尔德基金会医院646名专业人员中SARS-CoV-2的血清阳性率（ProSeCoV研究）。
Anaesth Crit Care Pain Med. 2020 Oct;39(5):595-596. doi: 10.1016/j.accpm.2020.08.003. Epub 2020 Aug 27.
3
Issues to be considered when planning sero-epidemiological studies in regions with a low incidence of SARS-CoV-2.在新冠病毒2型（SARS-CoV-2）低发病率地区规划血清流行病学研究时需考虑的问题。
Am J Infect Control. 2020 Sep;48(9):1127-1128. doi: 10.1016/j.ajic.2020.06.176. Epub 2020 Jun 17.
4
Reopening Society and the Need for Real-Time Assessment of COVID-19 at the Community Level.重新开放社会与社区层面新冠病毒病实时评估的必要性
JAMA. 2020 Jun 9;323(22):2247-2248. doi: 10.1001/jama.2020.7872.
5
Rising numbers of positive covid-19 tests in the UK.英国新冠病毒检测呈阳性的人数不断上升。
BMJ. 2020 Sep 17;370:m3605. doi: 10.1136/bmj.m3605.
6
SARS-CoV-2 diagnostic testing in Africa: needs and challenges.非洲的新型冠状病毒肺炎诊断检测：需求与挑战
Pan Afr Med J. 2020 Apr 14;35(Suppl 2):4. doi: 10.11604/pamj.2020.35.4.22703. eCollection 2020.
7
Diagnostic Stewardship: An Essential Element in a Rapidly Evolving COVID-19 Pandemic.诊断管理：快速演变的 COVID-19 大流行中的一个基本要素。
Mayo Clin Proc. 2020 Sep;95(9S):S17-S19. doi: 10.1016/j.mayocp.2020.05.039. Epub 2020 Jun 23.
8
[COVID-19 and Pulmonology: New Challenges and Opportunities].[新型冠状病毒肺炎与肺病学：新挑战与新机遇]
Acta Med Port. 2020 Oct 1;33(10):710. doi: 10.20344/amp.14760. Epub 2020 Sep 2.
9
Editorial: Making the Best Use of Test Kits for COVID-19.社论：充分利用新冠病毒检测试剂盒
Am J Epidemiol. 2020 May 5;189(5):363-364. doi: 10.1093/aje/kwaa080.
10
SARS-CoV-2 (COVID-19) serology: implications for clinical practice, laboratory medicine and public health.严重急性呼吸综合征冠状病毒2（COVID-19）血清学：对临床实践、检验医学和公共卫生的影响
CMAJ. 2020 Aug 24;192(34):E973-E979. doi: 10.1503/cmaj.201588. Epub 2020 Aug 3.
引用本文的文献
1
Potential for Bias in Prevalence Estimates when Not Accounting for Test Sensitivity and Specificity: A Systematic Review of COVID-19 Seroprevalence Studies.在不考虑检测敏感性和特异性时患病率估计中的偏倚可能性：COVID-19血清流行率研究的系统评价
Int J Public Health. 2025 Jul 15;70:1608343. doi: 10.3389/ijph.2025.1608343. eCollection 2025.
2
Influence of Seasonality and Public-Health Interventions on the COVID-19 Pandemic in Northern Europe.季节性和公共卫生干预措施对北欧新冠疫情的影响
J Clin Med. 2024 Jan 6;13(2):334. doi: 10.3390/jcm13020334.
3
Seroprevalence of SARS-CoV-2 immunoglobulin G in HIV-positive and HIV-negative individuals in KwaZulu-Natal, South Africa.南非夸祖鲁-纳塔尔省HIV阳性和HIV阴性个体中SARS-CoV-2免疫球蛋白G的血清阳性率。
Afr J Lab Med. 2023 Jun 29;12(1):2065. doi: 10.4102/ajlm.v12i1.2065. eCollection 2023.
4
Accounting for assay performance when estimating the temporal dynamics in SARS-CoV-2 seroprevalence in the U.S.当估计美国 SARS-CoV-2 血清流行率的时间动态时，要考虑检测性能。
Nat Commun. 2023 Apr 19;14(1):2235. doi: 10.1038/s41467-023-37944-5.
5
Canadian SARS-CoV-2 serological survey using antenatal serum samples: a retrospective seroprevalence study.加拿大使用产前血清样本的 SARS-CoV-2 血清学调查：一项回顾性血清流行率研究。
CMAJ Open. 2023 Apr 4;11(2):E305-E313. doi: 10.9778/cmajo.20220045. Print 2023 Mar-Apr.
6
Seroprevalence of SARS-CoV-2 in four states of Nigeria in October 2020: A population-based household survey.2020年10月尼日利亚四个州的新冠病毒血清阳性率：一项基于人群的家庭调查。
PLOS Glob Public Health. 2022 Jun 17;2(6):e0000363. doi: 10.1371/journal.pgph.0000363. eCollection 2022.
7
Cross-Canada Variability in Blood Donor SARS-CoV-2 Seroprevalence by Social Determinants of Health.基于健康社会决定因素的全加 SARS-CoV-2 血清流行率的血液捐赠者的跨加拿大变异性。
Microbiol Spectr. 2023 Feb 14;11(1):e0335622. doi: 10.1128/spectrum.03356-22. Epub 2023 Jan 10.
8
COVID-19 morbidity in Afghanistan: a nationwide, population-based seroepidemiological study.阿富汗的 COVID-19 发病情况：一项全国范围内基于人群的血清流行病学研究。
BMJ Open. 2022 Jul 27;12(7):e060739. doi: 10.1136/bmjopen-2021-060739.
9
Seroprevalence of Sars-Cov-2 antibodies among eligible blood donors of Peshawar, Pakistan.巴基斯坦白沙瓦符合条件的献血者中新冠病毒2型抗体的血清流行率。
Am J Blood Res. 2022 Jun 20;12(3):88-96. eCollection 2022.
10
Role of IgM Memory B Cells and Spleen Function in COVID-19.IgM 记忆 B 细胞和脾脏功能在 COVID-19 中的作用。
Front Immunol. 2022 Jun 30;13:889876. doi: 10.3389/fimmu.2022.889876. eCollection 2022.
本文引用的文献
1
Antibody testing for COVID-19: A report from the National COVID Scientific Advisory Panel.新型冠状病毒肺炎的抗体检测：国家新冠科学咨询小组的报告
Wellcome Open Res. 2020 Jun 11;5:139. doi: 10.12688/wellcomeopenres.15927.1. eCollection 2020.
2
Infection fatality rate of COVID-19 inferred from seroprevalence data.基于血清流行率数据推断的 COVID-19 感染病死率。
Bull World Health Organ. 2021 Jan 1;99(1):19-33F. doi: 10.2471/BLT.20.265892. Epub 2020 Oct 14.
3
Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19.无症状或轻症 COVID-19 康复者体内具有强大的 T 细胞免疫。
Cell. 2020 Oct 1;183(1):158-168.e14. doi: 10.1016/j.cell.2020.08.017. Epub 2020 Aug 14.
4
Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study.西班牙 2020 年人群血清流行病学研究（ENE-COVID）：全国范围内基于人群的血清流行病学研究。
Lancet. 2020 Aug 22;396(10250):535-544. doi: 10.1016/S0140-6736(20)31483-5. Epub 2020 Jul 6.
5
Diagnostic accuracy of serological tests for covid-19: systematic review and meta-analysis.血清学检测在 COVID-19 诊断中的准确性：系统评价和荟萃分析。
BMJ. 2020 Jul 1;370:m2516. doi: 10.1136/bmj.m2516.
6
Antibody tests for identification of current and past infection with SARS-CoV-2.用于识别当前和既往感染新型冠状病毒2的抗体检测。
Cochrane Database Syst Rev. 2020 Jun 25;6(6):CD013652. doi: 10.1002/14651858.CD013652.
7
Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections.无症状 SARS-CoV-2 感染的临床和免疫学评估。
Nat Med. 2020 Aug;26(8):1200-1204. doi: 10.1038/s41591-020-0965-6. Epub 2020 Jun 18.
8
Serum IgA, IgM, and IgG responses in COVID-19.新冠病毒肺炎中的血清IgA、IgM和IgG反应。
Cell Mol Immunol. 2020 Jul;17(7):773-775. doi: 10.1038/s41423-020-0474-z. Epub 2020 May 28.
9
A serological assay to detect SARS-CoV-2 seroconversion in humans.用于检测人类 SARS-CoV-2 血清转化的血清学检测方法。
Nat Med. 2020 Jul;26(7):1033-1036. doi: 10.1038/s41591-020-0913-5. Epub 2020 May 12.
10
IgA-Ab response to spike glycoprotein of SARS-CoV-2 in patients with COVID-19: A longitudinal study.新型冠状病毒肺炎患者针对 SARS-CoV-2 刺突糖蛋白的 IgA 抗体反应：一项纵向研究。
Clin Chim Acta. 2020 Aug;507:164-166. doi: 10.1016/j.cca.2020.04.026. Epub 2020 Apr 25.
Zotero 插件